1. Home
  2. OPK

OPK

OPKO Health Inc.

Logo OPKO Health Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Founded: N/A Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 857.3M IPO Year: 1995
Target Price: $3.17 AVG Volume (30 days): 9.6M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.25 EPS Growth: N/A
52 Week Low/High: $0.85 - $2.24 Next Earning Date: 05-01-2024
Revenue: $863,495,000 Revenue Growth: -14.01%
Revenue Growth (this year): -11.07% Revenue Growth (next year): 10.23%

Share on Social Networks: